These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 28428106)
1. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator. Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106 [TBL] [Abstract][Full Text] [Related]
2. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. Miyamoto H; Izumi K; Yao JL; Li Y; Yang Q; McMahon LA; Gonzalez-Roibon N; Hicks DG; Tacha D; Netto GJ Hum Pathol; 2012 Nov; 43(11):2033-40. PubMed ID: 22607700 [TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target. Go H; Kim PJ; Jeon YK; Cho YM; Kim K; Park BH; Ku JY Eur J Cancer; 2015 Sep; 51(14):1937-45. PubMed ID: 26238015 [TBL] [Abstract][Full Text] [Related]
4. Uridine 5'diphospho-glucuronosyltransferase 1A expression as an independent prognosticator in urothelial carcinoma of the upper urinary tract. Izumi K; Inoue S; Ide H; Fujita K; Mizushima T; Jiang G; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H Int J Urol; 2018 May; 25(5):429-435. PubMed ID: 29444544 [TBL] [Abstract][Full Text] [Related]
5. Utility of uroplakin II expression as a marker of urothelial carcinoma. Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628 [TBL] [Abstract][Full Text] [Related]
10. FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression. Lloreta J; Font-Tello A; Juanpere N; Frances A; Lorenzo M; Nonell L; de Muga S; Vázquez I; Cecchini L; Hernández-Llodrà S Hum Pathol; 2017 Apr; 62():222-231. PubMed ID: 28087474 [TBL] [Abstract][Full Text] [Related]
11. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival. Luo JH; Xie D; Liu MZ; Chen W; Liu YD; Wu GQ; Kung HF; Zeng YX; Guan XY Int J Cancer; 2008 Jun; 122(11):2554-61. PubMed ID: 18246597 [TBL] [Abstract][Full Text] [Related]
12. Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract. Inoue S; Ide H; Fujita K; Mizushima T; Jiang G; Kawahara T; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518027 [TBL] [Abstract][Full Text] [Related]
13. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters. Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538 [TBL] [Abstract][Full Text] [Related]
14. NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract. Kawahara T; Inoue S; Fujita K; Mizushima T; Ide H; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H Transl Oncol; 2017 Jun; 10(3):318-323. PubMed ID: 28327458 [TBL] [Abstract][Full Text] [Related]
15. Value of GATA3 immunostaining in tumor diagnosis: a review. Ordóñez NG Adv Anat Pathol; 2013 Sep; 20(5):352-60. PubMed ID: 23939152 [TBL] [Abstract][Full Text] [Related]
16. Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma. Makise N; Morikawa T; Kawai T; Nakagawa T; Kume H; Homma Y; Fukayama M Int J Clin Exp Pathol; 2015; 8(6):7203-9. PubMed ID: 26261615 [TBL] [Abstract][Full Text] [Related]
17. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters. Baspinar S; Bircan S; Yavuz G; Kapucuoglu N Pathol Res Pract; 2013 Jul; 209(7):418-23. PubMed ID: 23722017 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection. Chang WC; Chang YH; Pan CC Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder. Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878 [TBL] [Abstract][Full Text] [Related]
20. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]